ClinicalTrials.gg
RecruitingNCT07053098Updated Jun 3, 2026

External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting

An interventional study of Implementation Facilitation in Alcohol-Related Disorders and Psychiatric Disorder, sponsored by University of Maryland, Baltimore. Recruiting at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by University of Maryland, Baltimore · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Mar 2025, registered Jun 2025).
  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 107 studies in Alcohol-Related Disorders with a site in United States — 13 open to participants now, 18 under way, 1 of them phase 3. Alcohol-Related Disorders · United States.

Planned enrollment
64th of 94
40 · median 86
Started
2025
with 5 others
No phase
48 of 107
7 open now
Primary completion
2027-05
later than 7 of 17 live
Registered
105th of 107
by date
Lead sponsor
3 of 107
University of Maryland, Baltimore

Among the 107 studies in Alcohol-Related Disorders with a site in United States, this one is the 64th largest by planned enrollment of the 94 interventional ones that give a count, is one of 6 that started in 2025, is one of 48 with no phase, reaches primary completion later than 7 of the 17 other live ones, and was the 105th registered.

Alcohol-Related Disorders

156 studies on the registry are indexed under Alcohol-Related Disorders; 23 are open to participants now.

Browse Alcohol-Related Disorders studies →

Open to participants now

13 of the 107 studies in Alcohol-Related Disorders with a site in United States are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 16 Alcohol-Related Disorders studies recruiting now, 5 (31%) set no upper age limit and 7 (44%) stop at 75 or younger; 3 take children under 18; 5 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 107 studies in Alcohol-Related Disorders with a site in United States, or all of them as a file.
02

Study summary

This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics.

Read the detailed description

This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics. Guided by the integrated Promoting Action on Research Implementation in Health Services framework, an external facilitator will work with each clinics' internal champion to (1) provide clinic level education on MAUD in non-specialty care settings, (2) provide clinic level training in using a standardized screen measure for alcohol use disorder, documenting screening results in the electronic health record, and documenting alcohol use disorder diagnosis in the electronic health record, (3) help internal champions use an audit and feedback system for weekly review of MAUD education and prescribing, (4) help internal champions do weekly care coordination for patients with major mental illness and alcohol use disorder, and (5) make educational materials on MAUD available on site to patients so they are informed about these treatment options. Internal champions and clinics will have access to consultation from a MAUD clinician expert. These activities will take place across pre-implementation and implementation phases and will be followed by a post-implementation facilitation sustainment period during which clinics and champions continue implementation on their own. Formative Evaluation activities will take place throughout; at the end of the sustainment phase, MAUD outcomes will be assessed.

03

Conditions studied

  • Alcohol-Related Disorders
  • Psychiatric Disorder
04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • For prescribers: working as a prescriber, non-prescribing clinician, or administrator at one of the three participating clinics.
  • For patients: has major mental illness (major depressive disorders, bipolar disorder, schizophrenia spectrum disorders, other psychotic disorders; posttraumatic stress disorder)
  • For patients: has Alcohol Use Disorder and is being treated in one of the three participating clinics.

Exclusion criteria

Exclusion Criteria:

  • For all: age is less than 18 years old
  • For all: not able to complete
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Implementation Facilitation

    This Implementation Facilitation Intervention will include external facilitation, staff training, patient education, audit and feedback, and care coordination.

    Other: Implementation Facilitation

Interventions

  • OtherImplementation Facilitation

    Implementation facilitation is a multi-faceted process of enabling and supporting the adoption and integration of best practices into routine clinical care. It involves collaboration to understand a setting's challenges and barriers and working together to identify the best activities to address them. IF will incorporate External Facilitation, a problem-solving implementation strategy that builds supportive interpersonal relationships between an External Facilitator who is outside of the clinic who works with clinics and their identified internal champions to learn their unique barriers to implementation, use strategies to address these barriers, and plan for sustainability by integrating the practice into routine processes and workflows. Other implementation activities that will be used IF include staff training, patient education, audit and feedback, and care coordination.

06

What researchers measure

Primary outcomes

  1. Prescribing medications for alcohol use disorder

    Change in the proportion of eligible patients prescribed a medication for alcohol use disorder in the clinic

    Time frame: 6 months after the end of implementation facilitation

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for May 2027, 26 months after the start.

Of 49 non-industry interventional studies with no phase under Alcohol-Related Disorders, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 44. This study's planned 26 months is below that.

Counting every sponsor, half of 49 studies reached it within 30 months; a quarter within 17 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 30, 2025
First posted
Jul 8, 2025
StartActual
Mar 18, 2025
Primary completionEst.
May 31, 2027
CompletionEst.
May 31, 2027
Last update
Jun 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07053098
Responsible party
Melanie E Bennett (Professor, University of Maryland, Baltimore) — Principal investigator
First posted
Jul 8, 2025
Start date
Mar 18, 2025
Primary completion
May 31, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Jun 3, 2026

Study contacts

Melanie Bennett, PhD
Contact
mbennett@som.umaryland.edu
410-706-2490
Brian Brandler
Contact
bbrandler@som.umaryland.edu
410-706-2490
Melanie Bennett
principal investigator · University of Maryland, Baltimore

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion